Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data.

Abstract

BACKGROUND:

In 2016, the Zambian National Malaria Elimination Centre started programmatic mass drug administration (pMDA) campaigns with dihydroartemisinin-piperaquine as a malaria elimination tool in Southern Province. Two rounds were administered, 2 months apart (coverage 70% and 57%, respectively). We evaluated the impact of 1 year of pMDA on malaria incidence using routine data.

METHODS:

We conducted an interrupted time series with comparison group analysis on monthly incidence data collected at the health facility catchment area (HFCA) level, with a negative binomial model using generalized estimating equations. Programmatic mass drug administration was conducted in HFCAs with greater than 50 cases/1000 people per year. Ten HFCAs with incidence rates marginally above this threshold (pMDA group) were compared with 20 HFCAs marginally below (comparison group).

RESULTS:

The pMDA HFCAs saw a 46% greater decrease in incidence at the time of intervention than the comparison areas (incidence rate ratio = 0.536; confidence interval = 0.337-0.852); however, incidence increased toward the end of the season. No HFCAs saw a transmission interruption.

CONCLUSIONS:

Programmatic mass drug administration, implemented during 1 year with imperfect coverage in low transmission areas with suboptimal vector control coverage, significantly reduced incidence. However, elimination will require additional tools. Routine data are important resources for programmatic impact evaluations and should be considered for future analyses.

• Authors: Maya Fraser, John M Miller, Kafula Silumbe, Michael Hainsworth, Mutinta Mudenda, Busiku Hamainza, Hawela Moonga, Elizabeth Chizema Kawesha, Laina D Mercer, Adam Bennett, Kammerle Schneider, Hannah C Slater, Thomas P Eisele, Caterina Guinovart
• Journal: The Journal of infectious diseases (J Infect Dis) Vol. 225 Issue 8 Pg. 1415-1423 (04 19 2022) ISSN: 1537-6613 [Electronic] United States
• PMID: 32691047 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Chemical References

• Antimalarials

Topics

• Antimalarials (therapeutic use)
• Humans
• Incidence
• Malaria (drug therapy, epidemiology, prevention & control)
• Mass Drug Administration
• Zambia (epidemiology)